Weight loss drugs Ozempic and Wegovy would no longer be covered by California's health insurance for low-income people under ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Weight loss drugs like Ozempic and Wegovy can reduce alcohol cravings, scientists said, and users have reported drinking less ...